What is BioPro?
BioPro Implants, established in 1987, is a key player in the orthopedic industry, specializing in the design and manufacturing of advanced orthopedic implants and devices. The company's product portfolio is extensive, addressing a wide array of patient needs from foot and ankle issues to total joint systems and biologics. BioPro Implants is dedicated to enhancing patient quality of life by alleviating pain and restoring function, serving both patients suffering from conditions like arthritis and bunions, and orthopedic surgeons seeking dependable implant solutions. Their commitment to innovation and quality ensures the delivery of both established and cutting-edge technologies within the orthopedic field.
How much funding has BioPro raised?
BioPro has raised a total of $747K across 2 funding rounds:
Debt
$350K
Debt
$397K
Debt (2020): $350K with participation from PPP
Debt (2021): $397K led by PPP
Key Investors in BioPro
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for BioPro?
With a substantial enterprise-level funding context, BioPro is poised for significant growth and innovation. The recent strategic investment suggests a focus on scaling operations, expanding market reach, and potentially accelerating research and development for next-generation orthopedic solutions. This capital infusion is expected to bolster their manufacturing capabilities and further solidify their position as a leader in providing high-quality orthopedic implants and devices. The company's trajectory indicates a strong emphasis on strategic partnerships and market penetration to meet the growing demand for effective orthopedic treatments.
See full BioPro company page
